InvestorsHub Logo
Followers 789
Posts 33498
Boards Moderated 5
Alias Born 01/09/2001

Re: None

Friday, 07/10/2015 10:30:18 AM

Friday, July 10, 2015 10:30:18 AM

Post# of 91363
ARYC in a few here. FDA approval soon looks promissing. Nice SS and usually bounces from around here. Currently .0038 X .0039

From last 10Q
As of May 12, 2015, there were 64,371,019 shares of common stock outstanding.

From OTC Markets
Authorized Shares 480,000,000 a/o Apr 15, 2015
Outstanding Shares 64,371,019 a/o May 12, 2015
Float 30,712,404 a/o Apr 15, 2015




Brief Reports:

Arrayit Corp. (OTCQB: ARYC) leads and empowers the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure.

The company recently announced an agreement to supply custom Arrayit blood card technology to Vivos' Global Genome Vault, the only private human DNA vault on earth. Read the details of this development in the following report: http://bit.ly/_ARYC-AnalystReport

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.